181 results
Page 3 of 10
8-K
EX-99.1
4mn arbjezwkqn7
5 Nov 20
BioCryst Reports Third Quarter 2020 Financial Results and Upcoming Key Milestones
7:12am
8-K
EX-99.1
h2h8rmiu5ohfd
3 Sep 20
U.S. Government Exercises Option To Purchase Additional RAPIVABĀ® from BioCryst for Delivery to Strategic National Stockpile
7:06am
424B2
p2m sp6ercl9cjx
29 May 20
Prospectus for primary offering
6:07am
424B5
ekleefu0im198r
27 May 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.1
543k71
2 Apr 20
BioCryst Appoints Anthony Doyle Chief Financial Officer
7:55am
8-K
dwkd6mf19au ujp
2 Apr 20
BioCryst Appoints Anthony Doyle Chief Financial Officer
7:55am
8-K
EX-99.1
q91qwhyc 37al4w
5 Mar 20
BioCryst Reports Fourth Quarter and Full Year 2019 Financial Results and Upcoming Key Milestones
7:24am
8-K
EX-99.1
gdcz xhuf
13 Jan 20
BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference
6:32am
8-K
y7z 42jiz4i3wg66
13 Jan 20
BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference
6:32am
424B5
gjp6h8h9d
21 Nov 19
Prospectus supplement for primary offering
9:06am
424B2
2h5bodsa86dzei j7q
14 Nov 19
Prospectus for primary offering
5:25pm
424B5
z5154lk hjbu8
12 Nov 19
Prospectus supplement for primary offering
4:22pm
8-K
EX-99.1
8hzyxil
23 Sep 19
BioCryst Appoints Helen Thackray, M.D., to Board of Directors
9:45am